XML 34 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2015 $ 126,991 $ 796 $ 127,522 $ (1,327)
Balance, shares at Dec. 31, 2015   31,005    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 34,178 [1],[2]   34,178 [3]  
Unrealized loss on marketable securities, net of income tax expense 8 [4]     8
Gain (loss) on derivative securities, effective portion, net of income tax (benefit) expense (24) [4]     (24)
Foreign currency translation adjustment, including income tax expense (benefit) 126 [4]     126
Stock-based compensation expense 2,613 $ 2,613    
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   116    
Common stock issued under equity compensation plan, net of shares withheld for tax payments 117 $ 117    
Common stock issued under employee stock purchase plan, shares   24    
Common stock issued under employee stock purchase plan 381 $ 381    
Tax benefit related to stock-based awards 1,857 $ 1,857    
Repurchased shares, in shares   (320)    
Repurchased shares (5,390) $ (5,186) (204)  
Balance, shares at Dec. 31, 2016   30,825    
Ending balance at Dec. 31, 2016 160,857 $ 578 161,496 (1,217)
Beginning balance at Dec. 31, 2015 126,991 $ 796 127,522 (1,327)
Balance, shares at Dec. 31, 2015   31,005    
Balance, shares at Dec. 31, 2018   29,545    
Ending balance at Dec. 31, 2018 182,596 $ 215 183,290 (909)
Beginning balance at Dec. 31, 2016 160,857 $ 578 161,496 (1,217)
Balance, shares at Dec. 31, 2016   30,825    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 26,267 [1],[2]   26,267 [3]  
Unrealized loss on marketable securities, net of income tax expense (56) [4]     (56)
Gain (loss) on derivative securities, effective portion, net of income tax (benefit) expense 240 [4]     240
Foreign currency translation adjustment, including income tax expense (benefit) 774 [4]     774
Stock-based compensation expense 1,856 $ 1,884 (28)  
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   231    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (181) $ (181)    
Common stock issued under employee stock purchase plan, shares   37    
Common stock issued under employee stock purchase plan 487 $ 487    
Repurchased shares, in shares   (788)    
Repurchased shares (11,055) $ (2,768) (8,287)  
Balance, shares at Dec. 31, 2017   30,305    
Ending balance at Dec. 31, 2017 179,189 [5] $ 0 179,448 (259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 14,658   14,658  
Unrealized loss on marketable securities, net of income tax expense 58     58
Gain (loss) on derivative securities, effective portion, net of income tax (benefit) expense 7      
Foreign currency translation adjustment, including income tax expense (benefit) (715)     (715)
Stock-based compensation expense 1,981 $ 1,981 0  
Common stock issued under equity compensation plan, net of shares withheld for tax payments, in shares   192    
Common stock issued under equity compensation plan, net of shares withheld for tax payments (30) $ (30)    
Common stock issued under employee stock purchase plan, shares   38    
Common stock issued under employee stock purchase plan 444 $ 444    
Repurchased shares, in shares   (990)    
Repurchased shares (12,996) $ (2,180) (10,816)  
Balance, shares at Dec. 31, 2018   29,545    
Ending balance at Dec. 31, 2018 $ 182,596 $ 215 $ 183,290 $ (909)
[1] See Note 4.
[2] See Note 4.
[3] See Note 4.
[4] See Note 4.
[5] See Note 4.